Press releases

4 October 2016

Invent Farma and neuraxpharm appoint new group CEO

Following the acquisitions of Invent Farma and neuraxpharm by funds advised by Apax Partners, Stephan Walz has been appointed Chief Executive Officer. He will assume the newly-created role of Group CEO and will be leading Invent Farma’ and neuraxpharm’s activities across all markets.

27 September 2016

Apax Funds agree to sell Plantasjen to Ratos

Funds advised by Apax Partners agree to sell Plantasjen to Ratos.

8 August 2016

Azelis acquires Ametech, a leading speciality chemical distributor for agrochemical and fertiliser formulations

Azelis announces today that it has agreed to acquire 100% of Milan-based Ametech, a leading distributor for a complementary product basket of speciality chemicals for agrochemical and fertiliser formulations, feed and veterinary, polymerisation in emulsion, industrial applications and other markets.

2 August 2016

Funds advised by Apax Partners complete purchase of majority stake in Duck Creek Technologies from Accenture

Funds advised by Apax Partners have completed the acquisition of a majority stake in Duck Creek Technologies from Accenture. As part of the agreement, which was originally announced on April 18, Apax and Accenture have formed a joint venture in which Apax funds hold a 60 percent stake in Duck Creek Technologies, and Accenture retains a 40 percent stake.

19 July 2016

Funds advised by Apax Partners to acquire Dominion Marine Media

Funds advised by Apax Partners today announced that they have entered into a definitive agreement to acquire Dominion Marine Media, the leading global marine classifieds marketplace and marketing software solutions provider to marine brokers and dealers.

8 July 2016

Funds advised by Apax Partners to acquire the operating subsidiaries of Invent Farma

Funds advised by Apax Partners today announced that an entity controlled by them has entered into a definitive agreement to acquire the operating subsidiaries of Invent Farma S.L., a leading Spanish pharmaceutical company.